menu
    • menu

    Company profile for Qihan Biotech

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Co-founded in 2017 by two pioneers in genome editing technology, Qihan Biotech has world-leading capabilities in multiplexable genome editing as well as vast experience in Immune shielding. We apply these tools in both human stem cells and animal germline cells to deliver novel immune-privileged cell and organ therapies. A world in which cell and organ therapies are universally available to patients. Use multiplexable genome e...
    Co-founded in 2017 by two pioneers in genome editing technology, Qihan Biotech has world-leading capabilities in multiplexable genome editing as well as vast experience in Immune shielding. We apply these tools in both human stem cells and animal germline cells to deliver novel immune-privileged cell and organ therapies. A world in which cell and organ therapies are universally available to patients. Use multiplexable genome editing in combination with extensive knowledge in transplantation immunology to create immunologically privileged allogenic cells and xenogeneic organs for use as therapies to treat cancer. ect.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Qihan BiotechChina Flag
    Country
    Country
    China
    Address
    Address
    Rm 202, Chuanhua Kechuang Building, Xiaoshan Science and Technology park, Xiao...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.qihanbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Qihan Bio Presents at 2025 ASH Annual Meeting
    Qihan Bio Presents at 2025 ASH Annual Meeting

    03 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251103970936/en/Qihan-Biotech-Announces-Multiple-Presentations-at-the-2025-American-Society-of-Hematology-ASH-Annual-Meeting

    BUSINESSWIRE
    03 Nov 2025
    Share Share
    Qihan Biotech Announces FDA Clearance of IND for QT-019B
    Qihan Biotech Announces FDA Clearance of IND for QT-019B

    18 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250818100737/en/Qihan-Biotech-Announces-FDA-Clearance-of-IND-for-QT-019B-a-Universal-Dual-Target-CAR-T-Cell-Therapy-for-Refractory-Systemic-Lupus-Erythematosus

    BUSINESSWIRE
    18 Aug 2025
    Share Share
    iPSC-CAR-NK Cell Therapy Shows Breakthrough in Autoimmune
    iPSC-CAR-NK Cell Therapy Shows Breakthrough in Autoimmune

    25 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250624373154/en/iPSC-CAR-NK-Cell-Therapy-Clinical-Result-Published-in-Cell-Marking-a-Global-Breakthrough-in-Autoimmune-Disease-Treatment

    BUSINESSWIRE
    25 Jun 2025
    Share Share
    Qihan Biotech's CAR-T Research at ASGCT 2025
    Qihan Biotech's CAR-T Research at ASGCT 2025

    14 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250514459901/en/Qihan-Biotech-Presented-its-Breakthrough-CAR-T-Research-at-ASGCT-2025

    BUSINESSWIRE
    14 May 2025
    Share Share
    Qihan Biotech Appoints Naxin Yao to its Board of Directors
    Qihan Biotech Appoints Naxin Yao to its Board of Directors

    28 Jul 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230728036786/en

    BUSINESSWIRE
    28 Jul 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search